Table 1.
Characteristics of the study subjects.
Fig 1.
Endocannabinoid and related compounds plasma concentrations.
Box plots of plasma concentrations of 2-arachidonoyl glycerol (A), anandamide (B), 2-linoleoylglycerol (C), docosahexaenoylethanolamide (D), 2-oleoylglycerol (E), oleoylethanolamide (F), linoleoylethanolamide (G), and palmitoylethanolamide (H) of subjects from each of the body mass index (BMI) sub-groups. The median is represented as a line within the box plot and the mean is represented as a + sign. Significant differences (p<0.05) of endocannabinoids and related compounds concentrations between BMI subgroups are represented by asterisks (*).
Fig 2.
Box plots of odor threshold-discrimination-identification (TDI) scores (A), odor threshold scores (B), odor discrimination scores (C), and odor identification scores (D) of subjects from each of the body mass index (BMI) sub-groups. The median is represented as a line within the box plot and the mean is represented as a + sign. Discontinuous line in (A) represents the TDI score of 30.3 that separates normosmia from hyposmia. Significant differences (p<0.05) of olfactory scores between BMI sub-groups are represented asterisks (*).
Table 2.
Olfactory scores correlations.
Table 3.
Olfactory scores of study subjects in relation to different cofounding factors.
Table 4.
OIfactory scores and endocannabinoid concentrations in a subsample of individuals aged between 30–45 years old.